US Edition
FDA taps critic of COVID policies, drug industry to lead vaccines division
- Dr. Vinay Prasad was named on Tuesday by FDA Commissioner Marty Makary to lead the agency's vaccines and biotech drugs program, replacing longtime chief Dr. Peter Marks who resigned in March.
- Prasad gained wider attention during the COVID-19 pandemic after criticizing mask mandates, lockdowns, and expedited vaccine boosters from Pfizer and Moderna, raising questions about his regulatory approach.
- Prasad, a cancer and blood disorders expert at UCSF, has challenged FDA fast-track approvals, showing many cancer drugs lack evidence of improving or extending lives, and has called the FDA ineffective in social media and podcast appearances.
- Prasad criticized his predecessor Marks as merely approving decisions unquestioningly and expressed on Vivek Ramaswamy's podcast last year that Americans might fare better if the FDA were fundamentally restructured or even absent in its present state.
- Prasad’s appointment has sparked concern that vaccine and drug manufacturers could face increased regulatory scrutiny, potentially disrupting the predictability vital to drug development plans that extend over years or decades.
131 Articles
131 Articles
Former OHSU oncologist Vinay Prasad tapped by RFK Jr. to head FDA vaccine division
This story was originally published by The Lund Report, an independent nonprofit health news organization based in Oregon. It is republished with permission.Five years ago, working in Portland, Dr. Vinay Prasad was throwing stones from the side of the road. Now he is behind the wheel — heading a pivotal science program for the Trump administration.Prasad, a former Oregon Health & Science University assistant professor, has been a vocal critic of…
HOMESTEAD REVOLUTION - The HighWire
Del recaps ICAN’s explosive D.C. press conference exposing former FDA official Dr. Peter Marks for blocking recognition and support for the COVID-19 vaccine injured. Jefferey Jaxen reports on the health freedom movement sweeping U.S. states, a perplexing power outage in Spain and Portugal, and new fertility concerns tied to the COVID shot. Del is joined […]
Why Trump's Latest FDA Appointee May Imperil Agency's Vital Work
By appointing Dr. Vinay Prasad to run the Center for Biologics Evaluation and Research, the Trump regime has installed another prominent opponent of Covid-era public health policies to a key position at the Food and Drug Administration.CBER is responsible for ensuring the safety and efficacy of vaccines, biologic drugs, gene therapies and the blood supply. When FDA Commissioner Martin Makary announced Prasad’s appointment yesterday, he noted the…
Coverage Details
Bias Distribution
- 53% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
